Participant flow

Sunitinib in Treating Patients With Idiopathic Myelofibrosis · Source last updated 2014-05-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   37.5 mg orally daily for 6-week cycle

   id

   FG000

   title

   Sunitinib

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         7

      type

      Lack of Response

   2. reasons

      1. group Id

         FG000

         num Subjects

         4

      type

      Toxicities

   3. reasons

      1. group Id

         FG000

         num Subjects

         3

      type

      Disease Progression

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         14

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         0

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         14

      type

      NOT COMPLETED

   title

   Overall Study

recruitment Details

Recruitment Period: September 14, 2006 to December 17, 2007. All recruitment done at UT MD Anderson Cancer Center.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice